Backstage AACR Opening Ceremony waiting to receive the prestigious #AACR2024 Team
Science Award with neil ryan on behalf of Team Womb for our work that changed UK clinical practice such that all endometrial cancer patients are now offered testing for Lynch syndrome

#ICYMI iMATCH-ATTC is set to benefit from new investment into the Advanced Therapy Treatment Centre network alongside two other UK centres.

UoM Biology, Medicine and Health | The Christie NHS

Read more: mcrc.manchester.ac.uk/imatch-to-bene…

Check out the Clinical Updates on Bispecific Abs/TCE's session taking place during the upcoming Immune Effector Cell Therapies Workshop. Register today: show.jspargo.com/imsiect24/reg/

Great opportunity for paediatric haem or onc trainees keen to learn more about the clinical development of new therapies…

Happily haematology clinical research at The Christie can continue on Monday morning, as we all made it out of our escape rooms at our team building event!

Calling any haematology trainees that are interested in getting experience with cutting edge early phase clinical trials in myeloma, leukaemia and lymphoma.

Come and work with us, you’ll have fun and learn loads!

UCLH NIHR UCLH Biomedical Research Centre Jen O uclh.nhs.uk/work-with-us/c…
👇👇

🚨 NEWS 🚨

EU Medicines Agency CHMP recommends approval of cilta-cel, a BCMA-targeted CAR T-cell therapy, for the treatment of RRMM after ≥1 prior line of therapy, including an IMiD or PI, who have progressed the on last therapy and are refractory to lenalidomide.

Read more:…

Lot of room for improvement particularly with TP53 mut as we all appreciate in our own practice

Not unexpected but I’m sure there is more we can learn from the P1-3 development of magro- FDA Halts Clinical Studies of Magrolimab in AML, MDS targetedonc.com/view/fda-halts…

Come and join us at The Christie!

jobs.nhsbt.nhs.uk/Job/JobDetail?…

Are you passionate about #clinicaltrials and innovative trial methodologies?

Exciting paid summer vacation scholarship awaits undergraduates with the Early Phase and Adaptive Trials Group ICR-CTSU! tinyurl.com/2xe8x7ht

Deadline: 16/02/24

US colleagues, you would not believe how much road traffic chaos this 2cm of snow where I live is causing this morning! UK infrastructure cannot cope… but at least it looks pretty! 🤩

*Closing date 25/1/24* Looking for a new colleague be one of 7 consultants at QEUH. If you enjoy acute haematology and have a special interest in Myeloma we are a friendly team in a large teaching hospital with excellent registrar, ANP and CF support. apply.jobs.scot.nhs.uk/Job/JobDetail?…

Modifying Talquetamab Doses for Myeloma Continues Efficacy, Reduces Side Effects oncnursingnews.com/view/modifying… via @Oncology Nursing News

Hypomethylating Agent Monotherapy Compared With Hypomethylating Agent Plus Venetoclax Regimen Among Patients With Untreated TP53-Mutated AML hmpgloballearningnetwork.com/site/onc/confe…

Myeloma PFS curves looking like Hodgkin’s. Dara_VRd >> AHCT >> Dara_VRd >> DR maintenance. 4yrs PFS 84% and 65% MRD neg @ 10^~6, Triumph of science and research. Congrats to ⁦EMN⁩ and above all to myeloma patients. #ASH23 #msmm

Important data. Randomised trials of Ven based induction regimes in fit adults now essential. Provides underpinning rationale for UK Victor and ACT-AML-101 trial. Accelerating Clinical Trials

CellCentric presents positive clinical data at #ASH23 : inobrodib treating relapsed refractory multiple myeloma. Paper 2005: cellcentric.com/wp-content/upl… Emma Searle

Team Myeloma UK from #ECMC to #frailty #SMM #MMSM #scientificMM you name it we have it #UKMRA ⁦Charlotte Pawlyn⁩ ⁦Emma Searle⁩ DrDeanSmith @DrSaragooding collaborating in San Diego #ASH23 ⁦ASH⁩